Symbotic Inc... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMED | 31.40 | 0.83 | +2.73% |
| Fidelity Disruptive Medicine ETF (FMED) | |||
| FDEM | 35.64 | 0.41 | +1.16% |
| Fidelity Emerging Markets Multifactor ETF (FDEM) | |||
| XMHQ | 114.23 | 0.57 | +0.50% |
| Invesco S&P MidCap Quality ETF (XMHQ) | |||
| MYCN | 23.21 | -0.02 | -0.09% |
| State Street My2034 Corporate Bond ETF (MYCN) | |||
| VEGI | 44.18 | -1.07 | -2.36% |
| iShares MSCI Agriculture Producers ETF (VEGI) | |||
A.I.dvisor indicates that over the last year, SYM has been loosely correlated with SERV. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SYM jumps, then SERV could also see price increases.
| Ticker / NAME | Correlation To SYM | 1D Price Change % |
|---|---|---|
| SYM | 100% | +1.36% |
| Producer Manufacturing category (349 stocks) | 4% Poorly correlated | +1.32% |
Industry IndustrialMachinery
SYM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 08, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In 38 of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 81%.
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SYM as a result. In 68 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 64 cases where SYM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
SYM moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SYM crossed bullishly above the 50-day moving average on September 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 22 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +2.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where SYM advanced for three days, in 222 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 175 of 209 cases where SYM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. SYM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.698) is normal, around the industry mean (5.342). SYM's P/E Ratio (1050.000) is considerably higher than the industry average of (66.065). SYM's Projected Growth (PEG Ratio) (5.185) is slightly higher than the industry average of (1.879). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (2.064) is also within normal values, averaging (186.943).